Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial

Stephanie M. de Boer*, Melanie E. Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Meder, Petronella B. Ottevanger, Jonathan A. Ledermann, Pearly Khaw, Alessandro Colombo, Anthony Fyles, Marie-Helene Baron, Henry C. Kitchener, Hans W. Nijman, Roy F. Kruitwagen, Remi A. Nout, Karen W. Verhoeven-Adema, Vincent T. Smit, Hein Putter, Carien L. Creutzberg

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1114-1126
JournalLancet oncology
Issue number8
Publication statusPublished - Aug 2016

Cite this